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ARTICLE
Directed evolution of rRNA improves translation
kinetics and recombinant protein yield
Fan Liu 1,5, Siniša Bratulić 1,4,5, Alan Costello 1,2,5, Teemu P. Miettinen 3 & Ahmed H. Badran 1,2✉
In bacteria, ribosome kinetics are considered rate-limiting for protein synthesis and cell
growth. Enhanced ribosome kinetics may augment bacterial growth and biomanufacturing
through improvements to overall protein yield, but whether this can be achieved by
ribosome-specific modifications remains unknown. Here, we evolve 16S ribosomal RNAs
(rRNAs) from Escherichia coli, Pseudomonas aeruginosa, and Vibrio cholerae towards enhanced
protein synthesis rates. We find that rRNA sequence origin significantly impacted evolu-
tionary trajectory and generated rRNA mutants with augmented protein synthesis rates in
both natural and engineered contexts, including the incorporation of noncanonical amino
acids. Moreover, discovered consensus mutations can be ported onto phylogenetically
divergent rRNAs, imparting improved translational activities. Finally, we show that increased
translation rates in vivo coincide with only moderately reduced translational fidelity, but do
not enhance bacterial population growth. Together, these findings provide a versatile plat-
form for development of unnatural ribosomal functions in vivo.
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D irected evolution of ribosomal rRNA (rRNAs)
1,2 towards
unnatural bioactivities has highlighted plasticity in the
cellular translation apparatus. Mutations to rRNAs or
ribosomal proteins (r-proteins) can enhance translational
fidelity3, reduce translational kinetics4, endow antibiotic
resistance5, affect ribosome assembly6, and enhance the incor-
poration of noncanonical monomers or decode nonsense
codons1. However, it remains unknown whether the translation
rate or catalytic potential can be increased by ribosome-specific
modifications.
Given the large sequence space of an rRNA, powerful methods
of directed evolution are needed to access improved kinetic
translation capabilities. Classical directed evolution requires
extensive effort to maximize library diversity, fine-tune sequential
selection conditions, and suffers from limitations in their muta-
tional spectrum and library transformation efficiencies7.
A high-throughput methodology for directed evolution of
rRNAs could therefore facilitate unbiased investigations of ribo-
somal translation and may enable researcher-dictated biosyn-
thetic capabilities. In particular, orthogonal translation systems,
which create dedicated pools of researcher-controlled ribosomes
that are decoupled from cellular viability8, have enabled the
exploration of sequence-function relationships en route to
unnatural bioactivities1, permitted investigations into a mutation
of sequence essential for cell function, and enabled the discovery
of augmented ribosomal activities9.
Bolstered by this decoupled translation framework, we devel-
oped an orthogonal ribosome-dependent phage-assisted con-
tinuous evolution (oRibo-PACE) methodology that enables rapid
directed evolution of rRNAs towards researcher-defined activities.
We use this system to explore the interplay between translational
kinetics and fidelity through the evolution of 16S rRNAs from
three bacterial species. We characterize evolved rRNA mutants
through variable reporter gene and context dependencies in an
orthogonal translation system, and find two of three starting
rRNA scaffolds evolved variants that achieve higher kinetic
translation rates than those of wild-type E. coli rRNA in an E. coli
host. The discovered variants function in a context-independent
manner when evaluated using variable reporter gene, ribosome-
binding site (RBS), and alongside cognate heterologous
r-proteins. Through analysis of the evolved mutations, we identify
consensus mutations that impart improved translational activities
to a wide repertoire of heterologous ribosomes. Critically, evolved
rRNAs furnish ribosomes capable of greatly increasing the yield
of proteins bearing noncanonical amino acids in an orthogonal
translation system. Finally, we extend these findings to generate
cells harboring only evolved rRNA variants, showcasing elevated
proteome-wide translation rates as compared to wild-type E. coli
rRNA, with only minor reductions in translational fidelity. Our
findings showcase that ribosomes can be evolved for improved
protein yield, enhanced genetic code expansion, and faster
translation rates in living cells.
Results
Development of a PACE-compatible orthogonal translation
system. PACE has facilitated the exploration of sequence-
function relationships of biomolecules with diverse cellular
activities10–16. Briefly, PACE exploits the rapid M13 bacterioph-
age lifecycle and couples the production of plasmid-borne gIII,
encoding the minor coat protein pIII necessary for both bacterial
infection and membrane extrusion17, to the activity of the evol-
ving biomolecule encoded on a pIII-deficient phage genome. The
genetic diversity of the evolving biomolecule is easily tuned
through a small molecule-inducible expression of mutator pro-
teins from the mutagenesis plasmid (MP)18. Historically PACE
has been limited to protein-coding genes. We envisioned that
PACE could be extended to the directed evolution of orthogonal
rRNAs (o-rRNAs), allowing efficient traversal of mutational
landscapes and uncovering variants with altered translational
activity (Fig. 1a). To establish an o-rRNA PACE selection in E.
coli, we adapted an orthogonal translation genetic circuit19,20 to
integrate the M13 bacteriophage gIII (which encodes pIII),
yielding the Accessory Plasmid 1 architecture (AP1; Fig. 1b) and
concurrently engineered selection phages (SPs) to encode the
complementary o-rRNA operon. Functional o-rRNAs capable of
forming active ribosomes and translating the gIII mRNA using
the o-RBS would robustly produce pIII, yielding infectious phage
progeny.
While the previously reported o-antiRBSB efficiently directs
translation of an sfGFP reporter bearing the cognate o-RBSB
sequence (Fig. 1c)8, a direct adaptation of o-RBSB to AP1
rendered S206013 cells uninfectable by wild-type M13 phage,
indicating high background pIII expression. Thus, we developed a
two-stage selection to identify PACE-compatible o-RBS/o-
antiRBS pairs with reduced background translation by host
ribosomes. We first introduced a degenerate library of 47 RBS
variants (o-RBSlib, Fig. 1c) and assessed the infectivity of the
resultant cells to identify sequences poorly recognized by host
ribosomes (Supplementary Fig. 1a). This analysis revealed 33
putative o-RBS candidates, and we further characterized the most
abundant seven variants (Supplementary Fig. 1b). To discover
potential cognate o-antiRBSs, we introduced a degenerate library
of 46 antiRBS variants in the SP-borne E. coli o-rRNA (o-
antiRBSlib, Fig. 1c) into E. coli host cells bearing each of the seven
o-RBSs. Functional o-antiRBS sequences should efficiently
translate gIII and give rise to progeny phage (Supplementary
Fig. 1c–e). After further optimization of spacer sequences
(Supplementary Fig. 1f), we identified o-RBSH3 (Fig. 1c) as the
optimal orthogonal sequence for subsequent experiments. We
adapted o-RBSH3 to AP1 (AP1H3) yielding 40- to 163-fold
enrichment for SPs encoding the cognate o-antiRBSH3 (SPH3)
relative to SPs bearing the mismatched o-antiRBSB sequence
(SPB) (Fig. 1d).
While the o-RBSH3/o-antiRBSH3 pair enabled phage propaga-
tion in standing culture (Fig. 1d), we hypothesized that alternative
solutions may exist under continuous culture conditions. We
continuously propagated a degenerate SP library encoding 46
antiRBSs (o-antiRBSlib, Fig. 1c) using AP1H3 in S2060 cells
yielding comparable phage titers to SPH3, while SPB was rapidly
washed out (Fig. 1e). We analyzed the resulting SP populations at
40 h by Sanger sequencing (24 clones) and found that SPlib
converged on exclusively two variants: o-antiRBSH3-1 and
o-antiRBSH3-2 (Fig. 1c). Both variants robustly translate a LuxAB
luciferase reporter, showing a similar dynamic range to the initial
o-antiRBSH3 variant (Supplementary Fig. 1g). We note that
o-antiRBSH3-1, but not o-antiRBSH3-2, appeared in our initial
antiRBS library (Supplementary Fig. 1e), suggesting differential
o-ribosome activities may depend on culturing conditions.
Although we successfully identified functional o-antiRBS
sequences from an unbiased SP library, the final phage titers
were considerably lower than those in previous protein-based
PACE campaigns10,11,13–16. We noted that host cells in the
turbidostat reside at the transition between the exponential and
stationary phase, during which o-rRNAs may be inactivated by
hibernation factors21. Accordingly, we deleted factors known to
inhibit ribosome activity to improve the propagation of o-rRNA
SPs (Fig. 1f). Deletion of ribosome hibernation promoting factor
(HPF) from S206013 yielded host strain S3317, with a 3400-fold
improvement in SP propagation (Fig. 1g). Concurrently, we
prepared an AP architecture, AP2 (Fig. 1b), which encoded a
growth phase-independent constitutive promoter22 to simplify
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o-rRNA evolution experiments (Supplementary Fig. 2a–d) and
integrated the pSC101 origin of replication for stringent copy
number control23. When introduced into S3317 cells, AP2H3
supported SPH3 propagation 4831-fold more efficiently than the
mismatched SPB (Fig. 1g and Supplementary Fig. 2e).
We next competed all o-antiRBS SPs (Fig. 1b) using S3317/
AP2H3 under continuous flow at varying lagoon dilution rates.
We note that low lagoon flow rates (<1.0 vol h−1) led to poor SP
propagation, consistent with ribosome inactivation at saturated
cell densities (Supplementary Fig. 2f)21. We analyzed individual
SPs propagated at 2 vol h−1 using Sanger sequencing and found
that most SPs encoded o-antiRBSH3-1, in agreement with the SPlib
evolution experiment (Fig. 1e and Supplementary Fig. 1e). In
overnight enrichment assays in standing culture, SPH3-1 similarly
showed improved titers (up to 186-fold) over SPH3 (Supplemen-
tary Fig. 2g). Following additional strain engineering (ΔfhuA24) to
produce S3489 (Supplementary Fig. 2g, h) and plasmid
modification to yield the AP3 architecture (Fig. 1b) to limit
AP/SP recombination (Supplementary Fig. 2b, i–l), we found the
S3489/AP3H3/SPH3-1 combination to be the optimal orthogonal
translation system and used it for all subsequent experiments.
Continuous directed evolution of orthogonal ribosomes. We
and others have recently shown that rRNAs derived from het-
erologous microbes can robustly support E. coli viability upon
deletion of all host-derived rRNAs20,25. As only E. coli-derived
o-rRNAs have been successfully evolved to date1,26, we hypo-
thesized that diverse heterologous o-rRNA sequences may
undergo distinct evolutionary trajectories in PACE, yielding
variable solutions to identical selection conditions. However,
divergent heterologous ribosomes often suffer from reduced
starting activity in an E. coli chassis as compared to wild-type E.
coli ribosomes20. The 16S rRNA is a highly conserved sequence,
yet encoding poorly conserved residues often residing at the
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Fig. 1 Development of a PACE-compatible selection for orthogonal translation. a Schematic representation of an orthogonal rRNA-dependent PACE
selection. An engineered M13 bacteriophage (selection phage; SP) encodes the o-rRNA operon in place of gIII. Upon infection, functional orthogonal
ribosomes efficiently translate gIII from the accessory plasmid (AP), yielding infectious phage progeny. Efficient o-rRNA diversification is implemented via a
mutagenesis plasmid (MP). b AP and SP designs used in directed evolution campaigns. c A comparison of native and orthogonal RBS/antiRBS pairs used in
this study. d Preliminary analysis of o-rRNA-dependent phage production under low (0mM IPTG) or high (1 mM IPTG) mRNA concentrations using AP1H3
(n= 2 biological replicates). e Discovery of o-antiRBS variants under continuous culturing conditions using a degenerate library in the SP-borne o-rRNA.
f Schematic representation of known ribosome hibernation factors. g Comparison of phage enrichment assays using the constitutive AP2H3 (top) in wild-
type host (S2060) or host cells where ribosome hibernation factors have been deleted: hibernation promoting factor (Δhpf), ribosome modulation factor
(Δrmf), ribosome-associated inhibitor A (ΔraiA), or ribosomal silencing factor S (ΔrsfS) (n= 1 biological replicate). Source data are available in the Source
Data File.
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threshold for heterologous ribosome activity, we generated dele-
tions in E. coli-derived 16S o-rRNA and characterized their
activity levels using reporter and SP enrichment assays
(Fig. 2b–f). These experiments established that SPs bearing
o-rRNAs with activity levels ≥32% of WT E. coli o-rRNA robustly
propagate under stringent conditions.
Next, we identified P. aeruginosa (Pa) and V. cholerae (Vc)
heterologous o-rRNAs as promising candidates for oRibo-PACE,
as they showed comparable activity to E. coli-derived o-rRNA
(Fig. 3a) and could successfully propagate in standing culture,
albeit at lower efficiency than their E. coli counterpart (Fig. 3b).
To evolve heterologous rRNAs, we subjected starting rRNA
species to multi-stage selection regimes with increasing selective
pressure. We performed 218 h (~268 generations10) of PACE
using E. coli (SPEc), P. aeruginosa (SPPa), and V. cholerae (SPVc)
o-rRNAs while varying selection stringency over multiple
segments (Fig. 3b–d). In all segments, we employed a previously
optimized MP, MP618, to enhance o-rRNA sequence diversity,
and regularly increased lagoon flowrates to enhance selection
stringency.
In the first segment (S1= 0–68 h), we diversified the clonal SP-
borne o-rRNAs through genetic drift by employing a constitutive
promoter driving gIII expression from AP3H3 (proB22; Fig. 3b, d).
During the second segment (S2= 68–143 h), we increased
selection stringency by reducing the gIII promoter strength
8-fold ((pro422); Fig. 3b, d), resulting in a > 250-fold decrease in
SP propagation efficiency (Fig. 3b). During the third segment
(S3= 143–218 h), we incorporated a split-intein pIII14 strategy
where an inserted protein sequence increased the effective length
of gIII by 123% (425–947 amino acids) and decreased SP
propagation efficiency further by >120-fold (Fig. 3c, d and
Supplementary Fig. 3a–g). Finally, to examine the effect of
selection schedule on o-ribosome variant activities, we carried out
a fourth segment (S4= 68–143 h) using the split-intein pIII
approach and SP populations immediately following genetic drift
(S1→S4) to compare a shorter selection regime to the aforemen-
tioned longer version (S1→S2→S3) (Fig. 3d). We note that all SP
populations robustly propagated across all segments, with the
exception of SPPa during S2 (Fig. 3d and Supplementary Fig. 3f),
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Fig. 2 Establishing EP–SP correspondence via E. coli 16S rRNA truncation analysis. a Nucleotide conservation of the 16S rRNA which was used to guide
truncated rRNA studies. Structure generated via Ribovision60. b Composite of tested 16S rRNA truncations and binned by their effects on orthogonal sfGFP
reporter translation. Variants with sfGFP output below 25% are considered inactive. c Key deletions used in the SP analysis as mapped on the E. coli 16S
rRNA secondary structure. d Single and double 16S rRNA truncations variably affect orthogonal GFP reporter translation, providing a gradient of activities
for SP-based analyses. Data are normalized to untruncated E. coli 16S o-rRNA. Data reflect the mean and standard deviation of 3–4 biological replicates
(n= 3-4). e Enrichment assays of SPs encoding full-length and truncated E. coli 16S o-rRNAs. f Plaque assays showing the relationship between 16S o-rRNA
activity and plaque formation. Labels indicate the truncation and activity in orthogonal GFP reporter translation relative to the untruncated 16S E. coli
o-rRNA. Data reflect the mean and standard deviation of 1–11 biological replicates (n= 1–11). Source data are available in the Source Data File.
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suggesting accumulation of mutations to enable enhanced
o-rRNA activities. Furthermore, all three SP populations under-
went cognate 23S rRNA deletion at virtually identical time points
during oRibo-PACE (Supplementary Fig. 3h), reflecting com-
plementation with the host E. coli 23S rRNA as previously
described20.
Individual clone sequencing at the end of each segment
revealed sweeping mutations in all SP-borne o-rRNAs (Supple-
mentary Fig. 3i and Supplementary Tables 1–3). Collectively, V.
cholerae o-rRNAs developed the highest average number of
mutations per clone throughout all segments, while P. aeruginosa
o-rRNA retained the lowest number of mutations (Fig. 3e). This
trend is consistent with propagation efficiencies of the corre-
sponding SPs during oRibo-PACE (Fig. 3d). A number of unique
mutations became prevalent in each SP population at varying
segments: C1098U (E. coli, S3), G1415A (E. coli, S1), U409C (V.
cholerae, S3), and A434U (P. aeruginosa, S1) (Fig. 4a–c and
Supplementary Fig. 3i, Supplementary Tables 1–3). Interestingly,
we note varying levels of natural sequence conservation at the
discovered sites (Fig. 4d, e)27, suggesting that mutations at these
positions may not necessarily indicate functional relevance.
Notably, an identical mutation in h27 was evolved indepen-
dently in all o-ribosomes at different segments: A906G in E. coli
and in V. cholerae (S1), and A900G in P. aeruginosa (S3)
(Fig. 4a–c, f and Supplementary Fig. 3i, Supplementary
Tables 1–3). Two identical mutations were also found in the E.
coli (U904C, G1487A) and V. cholerae (U904C, G1488A)
populations (Fig. 4a–c, f and Supplementary Fig. 3i, Supplemen-
tary Tables 1–3). A906 and U904 (helix 27, E. coli numbering)
together with G1487 (h44) form an interface with protein uS12
(Fig. 4f) during tRNA selection and ensure translation
accuracy28–30. The observation of three converged mutations
(U904C, A906G, and G1487A) in the E. coli and V. cholerae
populations suggests adaptive evolution towards enhanced
translational output (Fig. 3d). The E. coli-only mutation
C1098U (h37) interacts with r-protein uS231 (Fig. 4f) during
the final S30 subunit assembly32, whereas G1415A is proximal to
G1487A (h44, Fig. 4f) and may influence tRNA selection. The V.
cholerae-only mutation U409C forms a wobble base pair with
G433 (h16) interacts with uS4, where its mutation to a cytosine
may yield a stronger C409-G433 Watson–Crick pair (Fig. 4f)31.
The P. aeruginosa-only mutation A434U (h17) is near the
binding site of protein uS43 (Fig. 4f). Taken together, these results
showcase hallmarks of both similar and independent evolutionary
trajectories to overcome identical selection regimes.
PACE-derived o-rRNAs show augmented translation effi-
ciencies. To assess the consequences of PACE-derived mutations
on o-ribosome function, we subcloned evolved o-rRNAs into
inducible expression plasmids (EPs) and evaluated their activities
in vivo using a battery of assays: (1) characterizing translation
rate using orthogonal cellular reporter proteins20, (2) quantifying
host E. coli growth burden33 during o-ribosome overproduction,
(3) investigating possible context-dependence effects on the
translation by using the unrelated B o-RBS/o-antiRBS system8,
(4) analyzing preferential use of E. coli host factors by evolved
heterologous o-ribosomes via complementation with cognate
ribosomal proteins20, (5) exploring improvements in genetic code
expansion through non-canonical amino acid (ncAA)
incorporation34, and (6) analyzing context independence of
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Fig. 3 Continuous directed evolution of orthogonal ribosomes. a Starting o-ribosome activity of E. coli (Ec), P. aeruginosa (Pa), and V. cholerae (Vc) o-
rRNAs, quantified using sfGFP production. Data reflect the mean and standard deviation of 8 biological replicates (n= 8). b Phage enrichment assays of
SPEc, SPPa, and SPVc in S3489 cells using APs encoding promoters of decreasing strength. c Phage enrichment assays of SPEc, SPPa, and SPVc in S3489 cells
encoding variable inserts within the intein-proBAPH3 architecture: GGS2 linker, MBP, and dT7RNAP. d Summary of PACE evolution trajectories. In the first
trajectory, oRibo-PACE was carried out in three segments (segments 1→ 2→ 3). In the second trajectory, a shorter oRibo-PACE campaign was carried out
in two segments (segments 1 → 4). In all segments, high levels of mutagenesis (MP6)18 were induced. Phage titers sampled during o-ribosome evolutions
and lagoon flowrates are shown on the bottom. e The average number of mutations per sequenced clone is highest in SP-borne o-rRNA derived from V.
cholerae, followed by that of E. coli, while o-ribosome from P. aeruginosa on average had the lowest number of mutations at the end of each PACE segment.
Colors blue (E. coli), pink (P. aeruginosa), and purple (V. cholerae) are consistent across plots. Source data are available in the Source Data File.
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rRNAs comparing everything to starting E. coli o-rRNA under
the same conditions (Fig. 5a).
Continuous monitoring of luminescence activity was used as a
real-time proxy of the translation rate for o-ribosomes. Using
kinetic luminescence output at fixed optical densities (OD600=
0.15, Supplementary Fig. 4a), we observed minimal activity
improvements of evolved E. coli o-rRNA variants from S2 and S4.
However, the six variants isolated from the longer S3 trajectory
showed higher (146–196%) activity compared to the starting E.
coli o-rRNA (Fig. 5b–d and Supplementary Fig. 4b). Only a single
P. aeruginosa o-rRNA variant evolved after 218 h (S3) of PACE
yielded similar activity to starting E. coli (96%) luminescence
output (Fig. 5c and Supplementary Fig. 4c). Remarkably, almost
half (11/24) of V. cholerae 16S o-rRNA variants produced higher
(109–186%) activities relative to E. coli (Fig. 5b–d and
Supplementary Fig. 4d). These observed differences in evolved
o-rRNA populations, which do not correlate with 16S sequence
identity to E. coli (P. aeruginosa: 85%; V. cholerae: 90%), suggest
that heterologous rRNA choice may affect directed evolution
campaign success by as yet unclear determinants.
Orthogonal ribosomes are known to negatively affect host cell
fitness, likely due to over-commitment of resources to the
production of supplementary ribosomes (Supplementary
Fig. 4e)20. We observed a previously reported burden for E. coli
o-rRNA expression on host cells33, and in some cases, these
effects are moderately amplified in evolved variants (Fig. 5b–d
and Supplementary Fig. 4e–h). In general, host doubling time
increased for o-rRNA mutants with respect to starting o-rRNAs
(61/67 mutants; 91%), and this trend was held for o-rRNA
mutants with enhanced o-ribosome activity as compared to
starting scaffold (49/53 mutants; 92.5%) (Fig. 5b–d). However,
expressing wild-type or evolved P. aeruginosa or V. cholerae
o-rRNAs exerted a lighter metabolic burden on the E. coli host
than expressing the corresponding E. coli o-rRNAs in many cases
(Fig. 5b–d and Supplementary Fig. 4f–h).
Representative variants from each rRNA origin and evolution
segments were selected for further evaluation based on kinetic
luminescence output. Using an orthogonal superfolder GFP
(sfGFP) reporter, we observed the highest o-ribosome activity
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Fig. 4 Shared consensus mutations in 16S rRNAs following continuous evolution. An overview of consensus rRNA mutations observed in oRibo-PACE for
each starting rRNA species and selection. Values represent % of sequenced clones from each segment (a–c). d Shannon entropy for positions where
consensus mutations were discovered in oRibo-PACE. e Phylogenetic divergence at positions mutated during oRibo-PACE (outlined squares) show no
correlation between a discovered o-rRNA mutation and nucleotide conservation at that position. Shannon entropy values and nucleotide abundance were
both obtained from RiboVision60. f Consensus rRNA mutations discovered in PACE and their locations on the ribosome. Most ribosomal proteins have
been omitted for clarity. A close-up view of h37 in the 16S rRNA and the C1098U mutation in relation to ribosomal protein uS2. Close-up locations of
U409C (V. cholerae only) and C440U (P. aeruginosa only) mutations in relation to ribosomal protein uS4. And a close-up view of mutations discovered by
≥2 rRNA evolution campaigns on h27 and h44 in relation to uS12. For all parts, images were generated from a 2.8-Å Thermus thermophilus 70S ribosome
structure (PDB 4v5161). All positions are numbered using E. coli 16S rRNA nomenclature. Source data are available in the Source Data File.
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we hypothesized that E. coli r-proteins may show limited ability
to catalyze heterologous ribosome assembly with rRNAs
sufficiently divergent to that of E. coli, limiting overall
functionality of the P. aeruginosa- and V. cholerae-derived
o-rRNAs. To explore this, we complemented o-rRNA variants
with cognate r-proteins which we have previously shown can
improve heterologous activity20. r-Protein complementation of P.
aeruginosa (using bS16, bS20) and V. cholerae (using bS1, uS15,
bS16, bS20) o-rRNAs showed greatly increased sfGFP production
as compared to the starting E. coli o-rRNA, corresponding to
122–147% and 146–629%, respectively (Fig. 5f). These findings
show that oRibo-PACE-derived o-rRNAs evolved to overcome
the designed selection pressure and did not appreciably adapt to
the E. coli host.
Orthogonal translation systems have been employed to
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Fig. 5 In-depth characterization of evolved o-ribosome activities. a o-rRNA variants from each oRibo-PACE segment were cloned into expression
plasmids (EPs) and tested alongside reporter plasmids (RPs) of variable genes, RBSs, and context dependencies. Luminescence activity calculated at
OD600= 0.15 plotted against host strain (S3489) doubling time is shown for o-rRNA variants derived from each species corresponding to selections;
b S1→S2, c S2→S3, and d S1→S4. Data reflect a mean of 1–72 biological replicates (n= 1–72). Select o-rRNA variants were prioritized based on
luminescence activity and evaluated for sfGFP production in the absence (e) or presence (f) of cognate heterologous ribosomal proteins (r-proteins).
Incorporation of the ncAA BocK for select variants in the absence (g) or presence (h) of cognate heterologous r-proteins. Data reflect mean and standard
deviation of 4–7 biological replicates (n= 4–7). i sfGFP yield through orthogonal translation and using either the B or H3 o-RBS show comparable activities
in most cases. j Consensus mutations U409C and G1487 discovered through oRibo-PACE were incorporated into rRNAs derived from phylogenetically
divergent bacterial species, and evaluated for sfGFP production in the presence or absence of cognate heterologous r-proteins. In all cases, data are
normalized to the activity of the starting E. coli o-rRNA activity. Starting rRNAs are shown as filled in bars or circles, whereas evolved variants are shown as
borders only. Data reflect the mean and standard deviation of 1–72 biological replicates. Where relevant, data are normalized to the activity of the starting
E. coli o-rRNA activity (dashed line). Starting rRNAs are shown as filled in bars or circles, whereas evolved variants are shown as borders only. Colors blue
(E. coli), pink (P. aeruginosa), and purple (V. cholerae) are consistent across plots. Source Data are available in the Source Data File.
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extended these capabilities to heterologous ribosomes. We,
therefore, evaluated select evolved o-rRNAs for ncAA incorpora-
tion by integrating an amber (UAG) stop codon in sfGFP (residue
Y15135) and assessed Nε-((tertbutoxy)carbonyl)-L-lysine (BocK)
incorporation using an established Methansarcina barkeri-
derived tRNA-synthetase pair34. E. coli-derived o-rRNA mutants
showed no significant increase in BocK incorporation over
starting E. coli o-rRNA (Fig. 5g). In the absence of cognate
phylogenetically divergent r-proteins, P. aeruginosa and V.
cholerae o-rRNA also resulted in negligible improvements in
ncAA incorporation over starting E. coli (Fig. 5g). However, upon
supplementation with cognate r-proteins, P. aeruginosa and V.
cholerae-derived evolved o-rRNAs improved ncAA incorporation
efficiency up to 195% and 908%, respectively (Fig. 5h). Context
dependence of translation initiation was also evaluated by
expressing sfGFP containing either B or H3 o-RBS, where we
observed a nearly uniform correlation and clustering by species
(Fig. 5i). Interestingly, only E. coli-derived o-rRNA variants
showed improvements in both B and H3 o-RBS contexts,
suggesting that they may have been biased by their initial
discovery using E. coli o-rRNAs (Fig. 5i).
Finally, we explored the functional relevance of mutations
observed with high frequency during the various oRibo-PACE
campaigns. Through singular and combinatorial mutations using
two unrelated heterologous o-rRNAs (Salmonella enterica and
Serratia marcescens o-rRNAs), we uncovered the combined
consensus mutations U409C+G1487A as improving the kinetic
capabilities of orthogonal ribosomes (Supplementary Fig. 4i, j).
Interestingly, this mutational combination was only observed in
the V. cholerae campaign, which typically showed greater
activities than the E. coli and P. aeruginosa counterparts across
all assays. Both consensus mutations were transplanted into
o-rRNAs from increasingly divergent microbes, which resulted in
general improvements to translation activities (Fig. 5j). This effect
was amplified when tested alongside the cognate r-proteins
(Fig. 5j). Excitingly, o-rRNAs from Alteromonas macleodii and
Marinospirillum minutulum increased activity up to 332% and
299 as compared to the starting E. coli o-rRNA scaffold,
respectively (Fig. 5j). Interestingly, a comparison of wild-type
and orthogonal ribosome activities showed that starting E. coli
o-ribosomes (B o-antiRBS) alongside the cognate reporter gene (B
o-RBS) affords a similar protein yield to wild-type E. coli
ribosomes alongside a wild-type reporter gene in an E. coli host
(Supplementary Fig. 4k). Accordingly, we normalized all reporter
assays to the starting E. coli o-rRNA of a given o-RBS context, as
enhancements seen within these assays are expected to show
improvements over wild-type E. coli rRNA. Cumulatively, these
extensive analyses demonstrated that oRibo-PACE-derived
o-rRNAs enabled the discovery of context-independent muta-
tions that broadly improved o-ribosome activities.
Kinetically enhanced rRNAs do not enhance population
growth. Analyses of evolved o-rRNA activities suggest that
oRibo-PACE can robustly influence ribosome translational
kinetics in engineered settings. To elucidate the physiological cost
of kinetically enhanced rRNA variants, we introduced the wild-
type antiRBS sequence into evolved o-rRNAs and assayed their
ability to complement the rRNA efficiency of SQ171 E. coli cells
and translate all cellular proteins (Fig. 6a and Supplementary
Fig. 5a)25.
In all cases, evolved 16S rRNAs robustly complemented the
ribosomal deficiency of this strain (used alongside native E. coli
23S, 5S; Fig. 6b–d and Supplementary Fig. 5b–f). We noted,
however, that all evolved variants from oRibo-PACE S3 and S4
that exhibited improved luminescence output (>145% of
respective wild-type) showed a concomitant proliferation rate
reduction in SQ171 cells (Fig. 6c, d): E. coli (6–12% reduction), P.
aeruginosa (11% reduction), V. cholerae (7–24% reduction). E.
coli ribosome content and therefore translation rate is thought to
correlate with cell proliferation36, yet kinetically evolved rRNA
variants did not result in faster proliferating strains. To further
explore this point, all E. coli and V. cholerae SQ171 strains were
assessed for cell vitality in nutrient-rich growth conditions (Davis
Rich Medium, DRM)15. Analysis of cellular respiration through
measurement of electron transport chain function (reductase
activity) is a reliable marker of vitality37. By assessing the
reductase activity and co-staining with propidium iodide, a
membrane integrity marker, using all E. coli and V. cholerae
mutants, we observed comparable reductase activity between all
strains (Fig. 6e) with indications of minor compromises in
membrane integrity as compared to wild-type E. coli (Fig. 6f). We
did not pursue further analyses using P. aeruginosa derived
ribosomes due to poor overall activities across most assays.
We hypothesized that the observed reduction in membrane
integrity and cell population growth may derive from protein
mistranslation by evolved rRNAs. Whereas perturbation of
translation rates through ribosomal protein (rpsD, rpsE) muta-
tions can impact the fidelity of protein synthesis5, to our
knowledge no such relationship between speed and fidelity has
been identified for kinetically enhanced translation. To explore
this relationship, we first tested complemented SQ171 strains for
sensitivity to aminoglycosides as a marker of amino acid mis-
incorporation38. Interestingly, we find that sensitivity to the
aminoglycosides kanamycin and gentamicin correlated negatively
with E. coli- (Pearson correlation coefficient, or PCC=−0.6086)
and V. cholerae-derived variants (PCC=−0.5248) (Fig. 6g, h and
Supplementary Fig. 6a, b). SQ171 strains encoding evolved
rRNAs also showed an increase in overall cell volume that
positively correlated with a population doubling time (Fig. 6i),
suggesting that kinetically enhanced ribosomes may impact cell
size by accumulating proteins at a non-physiological rate, thereby
impacting the balance between cell growth and division39. We
note, however, that increased cell volume under nutrient-rich
growth conditions is correlated with a higher average cell growth
rate40, yet this relationship was absent for our kinetically evolved
rRNA variants.
Motivated by these observations, we investigated the transla-
tional fidelity of evolved rRNAs. Complemented SQ171 strain-
derived sfGFP was subjected to trypsinization and label-free
LC–MS/MS to quantify amino acid mis-incorporation (substitu-
tion) events (Fig. 6j)41. For strains encoding wild-type E. coli and
the starting V. cholerae strain rRNAs, we observed a median
amino acid substitution frequency between 1 × 10−3 and 10−4,
suggesting these ribosomes translate with natural tolerable error
rates (Fig. 6k). All E. coli-derived and 4/6 tested V. cholerae-
derived mutants, display median amino acid substitution
frequencies above ≥2 × 10−3 (Fig. 6k), although we do not
observe a strong correlation between o-rRNA activity (Supple-
mentary Fig. 6c). Interestingly, specific regions of the sfGFP
transcript were enriched in mistranslation events in an o-rRNA-
independent manner (Supplementary Fig. 6d, e), although no
clear codon ambiguity or amino acid mistranslation preference
emerged from these analyses (Supplementary Fig. 6f).
PACE-evolved o-rRNA variants typically showed an enhanced
translation rate over starting E. coli rRNA under various reporter
gene and o-RBS contexts (Fig. 5). To investigate whether these
observations extended to proteome-wide translation, we quanti-
fied the relative translation rates of complemented SQ171 strains
through L-azidohomoalanine (AHA) (Fig. 6l) incorporation in
defined minimal medium and quantification following click-
chemistry labeling42. We observed higher average translation
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Fig. 6 Evolved rRNAs support proteome-wide translation at elevated levels. a The o-RBS of oRibo-PACE-derived rRNA variants was substituted with the
wild-type RBS, and used to complement SQ171 strains (resident plasmids cured by sucrose selection). O-ribosome luminescence activity plotted against
complemented SQ171 strain doubling times for all species corresponding to selections segment: b S1→S2, c S2→S3, and d S1→S4. Data reflect a mean of
1–72 biological replicates (n= 1–72). Select rRNA variants were prioritized based on luminescence activity and evaluated for cellular characteristics:
electron transport chain function as assessed through cellular reductase activity (e) and membrane integrity as assessed through propidium iodide entry
(f). Data represent mean fluorescence intensity (MFI) with the error shown as the standard deviation of three biological replicates (n= 3). SQ171 strain
sensitivity to the mistranslation-promoting aminoglycosides kanamycin (g) and gentamicin (h) negatively correlates evolved o-ribosome activity.
i Complemented SQ171 strains show increased volume concomitant with observed increases of the population doubling time. j Schematic representation of
the workflow used to analyze amino acid mistranslation rates through sfGFP purification and LC–MS/MS analysis. k The amino acid substitution frequency
of select rRNA variants via sfGFP expression, shown as a % of total amino acid detected at a given position. Data reflect sfGFP purified from six pooled
biological replicates (n= 6). Each point represents an identified amino acid substitution, the horizontal bar represents the median substitution frequency of
all misincorporations detected in the sample, and the distribution shown as the interquartile range. The gray bar represents average cellular amino acid
mis-incorporation limits. l The methionine (Met) analog L-azidohomoalanine (AHA) was used to determine proteome-wide translation rate through
unbiased cellular incorporation. m Mean slope of AHA incorporation calculated from 20-min time-course analysis. Data normalized to mean slope of wild-
type E. coli from each experimental run. n Complemented SQ171 cells show similar reductase activity and o membrane integrity during the AHA
incorporation assay. Data reflect the mean and standard deviation of three biological replicates run on different days (n= 3). Where relevant, data are
normalized to the activity of the starting E. coli o-rRNA activity, this is represented as a dashed line. Starting rRNAs are shown as filled in bars or circles,
whereas evolved variants are shown as borders only. Colors blue (E. coli), pink (P. aeruginosa), and purple (V. cholerae) are consistent across plots. Source
Data are available in the Source Data File.
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rates in V. cholerae mutants (S2.7, S3.7) and E. coli mutants (S3.5,
S3.7) as compared to E. coli and V. cholerae starting ribosomes
(Fig. 6m). Analysis of viable cells revealed an average AHA
incorporation rate increase of >2-fold by Vc mutants S2.7 and
S3.7 as compared to wild-type E. coli (Fig. 6m). Under these
conditions, we observed comparable degrees of reductase activity
between all strains (Fig. 6n) and slightly decreased membrane
integrity in the Vc mutant S3.7 and S4.4 strains (Fig. 6o). Overall,
these data showcase the ability of the discovered mutations to
impart enhanced kinetic properties to ribosomes in native
settings, and that faster translation results in a moderate
reduction in translational fidelity. These data indicate that
ribosome kinetic potential is not maximized but rather refined
within a cellular context to balance translation rate and error.
Discussion
Established models intimately link bacterial ribosome content,
proteome-wide protein synthesis rate, and population prolifera-
tion rate43. Given its critical role in modulating cellular growth
rate, the ribosome content of a cell is tightly regulated to mitigate
over-commitment of resources36. Indeed, rRNAs and ribosomal
proteins (r-proteins) can make up approximately half of the total
E. coli dry mass44. Bacteria encoding more ribosomal RNA
(rRNA) operons often show increased growth rates45 and
r-proteins are synthesized preferentially over all other proteins
during exponential growth46, suggesting that increases in the
cellular commitment to ribosome production may dictate the
growth rate of a cell. In addition to ribosome content, cellular
translation rate may be influenced by a multitude of other factors,
including the translation initiation efficiency47, aminoacylated
tRNA abundance48, elongation factor availability49, messenger
RNA (mRNA) codon usage50, and amino acid composition of the
nascent polypeptide51. Whereas reduction of ribosome elongation
rate can negatively impact bacterial proliferation rates52, it has
remained unclear if kinetically enhanced ribosomes would result
in a correspondingly amplified protein yield and rapid population
growth. Curiously, reduced translation kinetics can enhance the
fidelity of protein synthesis51, suggesting some interplay between
these two parameters. Here, we describe the first efforts, to our
knowledge, to enhance ribosome translation rates above natural
speeds.
To explore the kinetic potential of translation, we envisioned
that ribosome-directed evolution would provide access to geno-
types with faster-than-natural translation rates. To overcome
inherent challenges in ribosome-directed evolution, we developed
oRibo-PACE, which combines in vivo orthogonal translation6
and phage-assisted continuous evolution10. To afford this system,
we systematically optimized parameters of the platform known to
affect the efficiency of orthogonal translation: (1) o-RBS/o-
antiRBS interactions to limit crosstalk with host ribosomes, (2)
sensor plasmid architecture to enhance orthogonal translation
sensitivity, and (3) deletion of host hibernation factors that we
show, for the first time, can limit orthogonal translation cap-
abilities. These advances yield an orthogonal translation system
that supports phage propagation with high efficiency and mini-
mal crosstalk (>70,000-fold above background). We validated this
system using orthogonal Escherichia coli-derived ribosomes, and
extended these capabilities to two related heterologous ribosomes
from P. aeruginosa and V. cholerae20.
Convergent two and three-stage oRibo-PACE selection regimes
yielded o-rRNA variants with putatively enhanced kinetic activity
above starting rRNA scaffolds. We validated representative var-
iants using multiple reporter genes, o-RBS/antiRBS pairs, and
r-proteins complements, finding context-independent improve-
ments in protein translation. Interestingly, we discovered
consensus mutations at positions known to interact with ribo-
somal proteins uS2, uS4, and uS12, all of which play roles in
tRNA selection (Fig. 4)28,29,53, and suggesting general solutions
for rapid translation using diverse o-rRNA scaffolds. However, we
noted some discrepancies between activities of evolved hetero-
logous o-rRNA variants that cannot be exclusively attributed to
phylogenetic distance from E. coli, but may reflect incompatibility
between heterologous components and the host translational
machinery. In some cases, PACE-derived variants had contrasting
effects in orthogonal translation and SQ171 complementation
assays, indicating that requirements for these activities may not
be fully congruent.
Nonetheless, we find that oRibo-PACE-evolved ribosomes
imparted improved translation activities across a myriad of
assays, and in both native and orthogonal translation contexts. In
particular, orthogonal translation system development has
maintained a long-standing goal of improving the decoding of
nonsense codons and or incorporation of ncAAs for genetic code
expansion1. Combining oRibo-PACE discovered consensus
mutations and heterologous ribosome engineering achieved 630%
reporter protein yield (Fig. 5f). This same combination of ribo-
some evolution and engineering improved the incorporation of
ncAAs within our reporter protein by 908% over the current
state-of-the-art orthogonal translation system (Fig. 5h). We
expect that our findings, in particular, that starting rRNA tem-
plates can greatly impact selection outcome, will inform
approaches for ribosome engineering and directed evolution. In
addition, future-directed evolution efforts that integrate selections
for translational fidelity may provide greater insight into the
kinetics upper limit tolerated by living cells. Using methods and
resources described in this study, we envision the development of
robust capabilities for improved protein biomanufacturing and
genetic code expansion (DeBenedictis et al., submitted),
explorations of cell growth regulation, and illumination of the
fundamental structure–function relationships within the
ribosome.
Methods
Bacterial strains. All DNA manipulations were performed using NEB Turbo cells
(New England Biolabs) or Mach1F cells, which are Mach1 T1R cells (ThermoFisher
Scientific) mated with S2057 F′ to constitutively provide TetR and LacI. All
infection assays, plaque assays, and PACE experiments were performed with E. coli
S3317 or S3489 as indicated. Both strains were derived from E. coli S206013 and
modified using the recombineering method54 as follows: (i) scarless deletion of
hibernation promoting factor (HPF)21 to reduce rRNA inactivation; (ii) deletion of
fhuA, a lytic bacteriophage entry receptor24, to facilitate turbidostat PACE
experiments.
DNA cloning. Water was purified using a MilliQ water purification system (Mil-
lipore). Genes were amplified by PCR from native sources as previously
described20. All plasmids and selection phages were constructed using USER
cloning55. Briefly, a single internal deoxyuracil base was included at 15–20 bases
from the 5′ end of the primer. This region is described as the USER junction, which
specifies the homology required for correct assembly. USER junctions were
designed to contain minimal secondary structure, have 42 °C < Tm < 70 °C, and
begin with a deoxyadenosine and end with a deoxythymine (to be replaced by
deoxyuridine). Phusion U Hot Start DNA Polymerase (Life Technologies) is used
in primers carrying deoxyuracil bases. MinElute PCR Purification Kit (Qiagen) was
used to purify all PCR products to 10 μl final volume, which was quantified using a
NanoDrop 1000 Spectrophotometer (ThermoFisher Scientific). For USER assem-
bly, an equimolar ratio (up to 1 pmol each) of PCR products carrying com-
plementary USER junctions were mixed in a 10 μl reaction containing 0.75 units
DpnI (New England Biolabs), 0.75 units USER (Uracil-Specific Excision Reagent;
Endonuclease VIII and Uracil-DNA Glycosylase) enzyme (New England Biolabs),
1 unit of CutSmart Buffer (50 mM potassium acetate, 20 mM Tris-acetate, 10 mM
magnesium acetate, 100 μg ml−1 BSA at pH 7.9; New England Biolabs). The
reactions were incubated at 37 °C for 20 min, followed by heating to 80 °C and slow
cooling to 4 °C at 0.1 °C s−1 in a thermocycler. The hybridized constructs were
directly used for heat-shock transformation of chemically competent NEB Turbo E.
coli cells or Mach1F E. coli cells. Agar-2xYT plates (1.8%; United States Biological)
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supplemented with the appropriate antibiotic(s) were used to select for
transformants.
For selection phage cloning, the hybridized constructs were transformed into
chemically competent S3489 cells carrying the accessory plasmid pJC175e15, where
pIII is produced in response to phage infection. After recovery for 12 h at 37 °C at
300 rpm in 2xYT media (United States Biological), the culture was centrifuged for
2 min at 10,000 × g and the supernatant was purified using 0.22 μm PVDF
Ultrafree centrifugal filter (Millipore). The titer of each clonal phage stock was
determined through plaque assays (see the section below). In all cases, cloned
plasmids and phages were verified by Sanger sequencing using a template
generated using the TempliPhi 500 Amplification Kit (GE Life Sciences) according
to the manufacturer’s protocol.
Plaque assays. S3317 or S3489 cells carrying the accessory plasmid of interest
were grown at 37 °C to OD600= 0.6–0.9 in 2xYT (United States Biological) liquid
media supplemented with the appropriate antibiotics. The stock of phage super-
natant was filtered using a 0.22 μm PVDF Ultrafree centrifugal filter (Millipore
Sigma) and diluted in three, 100-fold serial dilution increments to yield four total
samples (undiluted, 102-, 104-, and 106-fold diluted). For each sample, 10 μl of
phage was added to a sample library tube (VWR). S3317 or S3489 cells carrying the
accessory plasmid of interest were grown at 37 °C to OD600= 0.6–0.9 in 2xYT
(United States Biological) liquid media supplemented with the appropriate anti-
biotics. Next, 150 μl of cells were added to each library tube containing phage.
Within 1–2 min of infection, 1 ml of warm (~55 °C) top agar (0.4% agar-2xYT)
supplemented with 0.04% Bluo-Gal (Gold Biotechnology) was added to the phage/
cell mixture. After mixing by pipetting up and down once, each 1.16-ml mixture
was plated onto one quadrant of a quartered plate with 2 ml of bottom agar (1.8%
agar-2xYT). After solidification of the top agar, the plates were grown overnight
(~18 h) at 37 °C before plaques, stained blue following Bluo-Gal cleavage, could be
observed.
Enrichment assays. S3317 or S3489 cells carrying the accessory plasmid of interest
were grown in Davis rich media (DRM) media15 supplemented with the appro-
priate antibiotics to OD600= 0.2. The SP supernatant was added to a final titer of
105 pfu ml−1 and grown for 14–18 h in a 37 °C shaker at 300 rpm. Cultures were
centrifuged using a table-top centrifuge for 2 min (10,000 × g). The supernatant
was filtered through a 0.22 μm PVDF Ultrafree centrifugal filter (Millipore Sigma)
and titered by plaque assay on S3317 or S3489 cells with pJC175e (total phage
titer), S3317 or S3489 cells with proCAP3H3-1 (activity-dependent phage titer,
pAB171c), and/or S3317 or S3489 cells without any AP (recombinant M13-like SP
titer). If necessary, purified phage samples were stored overnight at 4 °C prior to
plaquing.
PACE. Host cell cultures, lagoons, media, and the PACE apparatus were prepared
as previously described10. Briefly, MP618 was co-transformed into chemically
competent S3489 or S3317 cells alongside the AP of interest and recovered for
45 min at 37 °C using DRM supplemented with 25 mM D-fucose to ensure MP
repression via catabolite repression by glucose (a component of DRM) and com-
petitive inhibition of araC by D-fucose56,57. Transformations were selected on 1.8%
agar-2xYT plates containing kanamycin (30 μgml−1), chloramphenicol (40 μgml−1),
25 mM glucose (United States Biological), and 25 mM D-fucose (Carbosynth). After
incubation at 37 °C for 12–18 h, six individual colonies were picked, resuspended in
DRM, 10-fold serially diluted and plated on 1.8% agar-2xYT plates with kanamycin
(30 µg ml−1), chloramphenicol (40 μg ml−1) and containing either 25 mM arabi-
nose (Gold Biotechnology) or 25 mM glucose and 25 mM D-fucose. After incu-
bation for 12–18 h at 37 °C, the plates were examined to confirm arabinose
sensitivity. Concomitant with the aforementioned plating step, the resuspended
colonies and dilutions thereof were used to inoculate liquid cultures in DRM
supplemented with kanamycin (30 μg ml−1), chloramphenicol (40 μg ml−1),
25 mM glucose, and 25 mM D-fucose. The cultures were grown in a 37 °C shaker at
900 rpm (Infors HT Multitron Pro) to OD600= 0.2, at which point 1-ml of cells
were added directly to 300 ml of fresh DRM in the turbidostat. The turbidostat
culture was maintained at 300 ml and optical density was maintained at
OD600= 0.8–0.9 using a TruCell2 probe10. All lagoons supplied by the turbidostat
were maintained at 40 ml, and diluted as described previously10. Prior to infection
with SPs, lagoons were supplemented to a final concentration of 25 mM arabinose
using a syringe pump (New Era Pump Systems) for 1 h to induce the MP. At the
indicated time points, samples were collected from each lagoon and SP was purified
as described above.
Mutagenesis during PACE. The basal mutation rate of replicating filamentous
phage in E. coli is 7.2 × 10−7 substitutions per base pair per generation, which is
sufficient to generate all possible single but not double mutants of a given 1000 base
pair gene in a 40-ml lagoon after one generation of phage replication. For the 16S
ribosomal subunit (1542 base pairs), a basal mutation rate of 7.2 × 10−7 sub-
stitutions per base pair per generation applied to 2 × 1010 copies of the gene
(a single generation in a 40-ml lagoon) yields ~2.2 × 107 base substitutions
(7.2 × 10−7 substitutions per base pair * 1542 base pairs * 2 × 1010 copies), which
could cover all 4.6 × 103 single point mutants and all ~2.1 × 107 double point
mutants. Arabinose induction of the high-potency mutagenesis plasmid MP618
increases the phage mutation rate to 7.2 × 10−3 substitutions per base pair per
generation, yielding ~2.2 × 1011 substitutions spread over 2 × 1010 copies of the
gene after a single generation. This elevated mutation rate is sufficient to cover all
possible single mutants (4.6 × 103 possibilities), double mutants (2.1 × 107 possi-
bilities), and triple mutants (9.9 × 1010 possibilities) after a single phage generation.
Luminescence assays. Log-phase (OD600= 0.3–0.5) S3489 cells carrying the
reporter plasmid (RP) pFL19c grown in 2xYT (United States Biological) was made
chemically competent, later transformed with the desired EP, and recovered for 2 h
in Terrific Broth (Millipore Sigma). All transformations were plated on 1.8% agar-
2xYT plates (United States Biological) supplemented with kanamycin (30 µg ml−1)
and carbenicillin (50 µg ml−1). The plates were incubated for 12–18 h in a 37 °C
incubator. Colonies transformed with the appropriate EP were picked the following
day and grown in DRM-containing kanamycin (30 µg ml−1) and carbenicillin
(50 µg ml−1) for 18 h. Following overnight growth of the EP/RP-carrying strains,
cultures were diluted 100-fold into fresh DRM supplemented with kanamycin
(30 µg ml−1) and carbenicillin (50 µg ml−1). The cultures were induced with
anhydrotetracycline (1000 ng ml−1), and 200 μL of each culture was transferred to
a 96-well black wall, clear bottom plate (Costar), and topped with 20 µl of mineral
oil (Millipore Sigma). OD600 and luminescence values for each well were monitored
using an Infinite M1000 Pro microplate reader (Tecan) over 15 h. Each variant was
assayed in 8–24 biological replicates. Luminescence activities were tabulated at
OD600= 0.15 in all cases.
Fluorescent protein assays. Chemically competent 3489 were transformed with
ribosome expression plasmid (EP) and desired reporter plasmid (RP), and recov-
ered for 2 h in Terrific Broth (Millipore Sigma). All transformations were plated on
1.8% agar-2xYT plates (United States Biological) supplemented with kanamycin
(30 µg ml−1) and carbenicillin (50 µg ml−1). The plates were incubated for 12–18 h
in a 37 °C incubator. Colonies transformed with the appropriate EP were picked
the following day and grown in DRM-containing kanamycin (30 µg ml−1), car-
benicillin (50 µg ml−1), and anhydrotetracycline (1000 ng ml−1). After growth for
16–24 h at 37 °C with 900 rpm shaking, 200 μl of each culture was transferred to a
96-well black wall, clear bottom plate (Costar), and topped with 20 µl of mineral oil
(Millipore Sigma). OD600 and fluorescence values (excitation at 485 nm, emission
at 510 nm) for each well were monitored using an Infinite M1000 Pro microplate
reader (Tecan) or Spark plate reader (Tecan). Each variant was assayed in 4–8
biological replicates. Fluorescent protein yields were normalized to culture OD600
in all cases.
ncAA incorporation assays. Chemically competent 3489 were transformed with
complementary plasmid (CP) pTECH Mb PylRS IPYE34 with resistance changed
for DHFR, and desired EP and RP (pAB140g (WT sfGFP) or pAMC025a
(UAG151 sfGFP) or pAMC016a (WT luxAB) or pAMC016b (UAG luxAB)), and
recovered for 2 h in Terrific Broth (Millipore Sigma). All transformations were
plated on 1.8% agar-2xYT plates (United States Biological) supplemented with
trimethoprim (3 µg ml−1), kanamycin (10 µg ml−1), and carbenicillin (15 µg ml−1).
The plates were incubated for 12–18 h in a 37 °C incubator. Colonies transformed
with the appropriate EP and RP were picked the following day and grown in DRM-
containing trimethoprim (3 µg ml−1), kanamycin (10 µg ml−1), and carbenicillin
(15 µg ml−1) for 20–24 h. Overnight cultures were 100-fold for luminescence assays
in fresh DRM containing; (3 µg ml−1), kanamycin (10 µg ml−1), carbenicillin
(15 µg ml−1), anhydrotetracycline (40 ng ml−1), with or without Nε-((tertbutoxy)
carbonyl)-L-lysine (BocK) (1 mM) (Bachem). For sfGFP assays, colonies were
picked directly into complete assay media. OD600 and luminescence values for each
assay were monitored using an Infinite M1000 Pro microplate reader (Tecan) or
Spark plate reader (Tecan). Each variant was assayed in 4–8 biological replicates.
Luminescence activities were tabulated at OD600= 0.15 in all cases. Fluorescent
protein yield was normalized to culture OD600 at saturation (OD600 ~ 1.5).
SQ171 complementation assays. Log-phase (OD600= 0.3–0.5) cells of SQ17125,58
grown in 2xYT (United States Biological) were transformed with the desired EP,
and recovered for 5 h in 2xYT in a 37 °C shaker. The recovery culture was cen-
trifuged at 10,000 × g for 2 min, then the pellet was resuspended in 100 µl 2xYT.
The resuspended cells were diluted serially in seven, 10-fold increments to yield
eight total samples (undiluted, 101-, 102-, 103-, 104-, 105-, 106-, and 107-fold
diluted). To determine the efficiencies of EP transformation and counter-selectable
plasmid curing, 3 μl of each sample of the diluted series were plated on 1.8% agar-
2xYT plates (United States Biological) supplemented with spectinomycin
(100 μg ml−1) and carbenicillin (50 μg ml−1), with or without 5% sucrose (Milli-
pore Sigma). For picking single colonies, the remaining undiluted cells were plated
on 1.8% agar-2xYT plates (United States Biological) containing spectinomycin
(100 μg ml−1), carbenicillin (50 μg ml−1), and 5% sucrose. All plates were grown
for 12–18 h in a 37 °C incubator. Colonies transformed with the appropriate EP
and surviving sucrose selection were picked and grown in DRM-containing
spectinomycin (100 μg ml−1), carbenicillin (50 μg ml−1), and 5% sucrose. Follow-
ing overnight growth of the EP-carrying strains, cultures were diluted 250-fold into
fresh DRM-containing spectinomycin (100 μg ml−1) and carbenicillin (50 μg ml
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−1). From the diluted cultures, 150 μl of each culture was transferred to a 96-well
black wall, clear bottom plate (Costar), topped with 20 µl of mineral oil, and the
OD600 was measured every 5 min over 15 h. Separately, 400 µl of each diluted
culture was supplemented with kanamycin (30 µg ml−1) and grown in a 37 °C
shaker at 300 rpm. Colonies that survived selection in kanamycin were excluded
from the final analysis, as survival in kanamycin indicates the persistence of the
resident pCSacB plasmid (which carries a KanR resistance cassette). The doubling
time of each culture was calculated using the Growthcurver package (version
0.3.0)59 in R (version 3.5.2).
Cell volume measurement. Complemented SQ171 strains were grown overnight
16–18 h in a 37 °C incubator DRM-containing spectinomycin (100 μg ml−1) and
carbenicillin (50 μg ml−1). Overnight cultures were then diluted 100-fold in fresh
DRM-containing spectinomycin (100 μg ml−1) and carbenicillin (50 μg ml−1).
Upon reaching the early log-phase (OD600= 0.1–0.15), cells were diluted 10-fold to
synchronize cultures and harvested when the early log-phase was reached again
(OD600= 0.1–0.15). Cells were then placed on ice and cell volumes were measured
in filtered PBS (0.2 µm filter) using Coulter Counter (Beckman Coulter) with a
20 µm aperture. Particles smaller than 0.4 µm3 in volume were excluded from the
analysis. Measurements were calibrated using NIST traceable 3.0 µm diameter
polystyrene beads (ThermoFisher).
Cell viability and AHA incorporation assays. SQ171 strains were grown for 24 h
in M9 minimal media supplemented with all amino acids (defined as M9AA):
M9 salts (Teknova), [0.4% w/v] D-glucose, [3.4 mgml−1] thiamine hydrochloride,
[1 mM] MgSO4, [0.25 mM] CaCl2, [1.33 mg l−1] amino acid mix (-Methionine)
(MANU), 200 µM L-Methionine (Sigma Aldrich), spectinomycin (100 μg ml−1)
and carbenicillin (50 μg ml−1). Overnight cultures were diluted 100-fold in fresh
M9AA and grown to OD600= 0.1–0.15. Cultures were synchronized by diluting
once more by 10-fold and continuing to grow. At OD600= 0.1–0.15, cultures were
harvested by centrifugation at 3000 × g for 5 min, media was exchanged for M9AA-
M (defined as M9AA excluding L-methionine), and cultures returned to 37 °C
incubator at 300 rpm. After 1 h, M9AA-M outgrowth cells were treated with 200
µM L-azidohomoalanine (AHA) (Click Chemistry Tools) and BacLight Redox-
Sensor Green Vitality Kit reagents (Invitrogen) per the manufacturer protocols for
5, 10, 15, 20, or 30 min at 37 °C and 300 rpm. AHA incorporation was blocked at
each time interval by adding 200 µg ml−1 chloramphenicol, whereas RedoxSensor
Green was blocked at each time interval by adding 10 mM NaN3. Negative control
samples for AHA incorporation and cell vitality were treated with 200 µg ml−1
chloramphenicol or 10 mM NaN3, respectively, 10 min prior to AHA or Redox-
Green addition. Following AHA incorporation and vitality labeling, cells were
washed using 0.5 ml PBS, fixed in 3.8% PFA for 10 min at room temperature,
washed twice with PBS, permeabilized with 0.2% Triton X-100 for 10 min in RT,
and washed twice more in PBS. Samples were stored at 4 °C for subsequent Click-
IT chemistry. Fixed and permeabilized cell samples were mixed with Click-&-Go
Cell Reaction Buffer (Click Chemistry Tools) containing 2.5 µM AlexaFluor 405
Alkyne (Click Chemistry Tools) according to manufacturer instructions, and were
incubated for 30 min in the dark at room temperature, then washed twice with PBS.
Labeled cells were analyzed with BD Biosciences flow cytometer LSR II HTS with
excitation lasers at 405, 488, and 561 nm and emission filters at 450/50, 515/20, and
610/20 nm. Cells were gated on forward and side scatter, and particles/cells with
minimal vitality labeling were excluded. The AHA incorporation rate represents
the rate of linear increase in population mean AHA incorporation over 20 min. For
viability assays not investigating AHA incorporation, strains were grown in DRM.
Overnight cultures were diluted 100-fold in fresh M9AA and grown to
OD600= 0.1–0.15. Cultures were again synchronized by diluting once more by 10-
fold and continuing to grow. At OD600= 0.1–0.15, cultures were labeled with
BacLight RedoxSensor Green Vitality Kit reagents (Invitrogen) per the manu-
facturer protocols, for 30 min at 37 °C with 300 rpm shaking. Flow data were
analyzed using FlowJo v10.
Aminoglycoside sensitivity assays. SQ171 strains carrying wild-type or evolved
rRNA variants were grown in DRM-containing spectinomycin (100 μg ml−1) and
carbenicillin (50 μg ml−1) for 12–18 h. Overnight cultures were diluted 50-fold in
fresh DRM-containing spectinomycin (100 μg ml−1), carbenicillin (50 μg ml−1),
and mixed 1:1 with a dilution series of kanamycin or gentamicin (64, 32, 16, 8, 4, 2,
1, 0.5, 0.25 μg ml−1). Cultures were grown at 37 °C with shaking, 900 rpm, over-
night for 24 h. OD600 for each well was quantified using an Infinite M1000 Pro
microplate reader (Tecan). IC50 values for kanamycin and gentamicin resistance of
each strain were calculated in Prism (v 9.1.0).
Protein purification. SQ171 strains transformed with pED17x1 (sfGFP with
C-terminal His-tag) were lysed by B-per (ThermoFisher), 4 ml per gram weight of
the pellet. To each sample, 120 µl of B-per+ protease inhibitor (Roche) was added
and incubated for 1 h at room temperature with gentle rocking. Soluble protein was
fractionated by centrifugation at 16,000 × g for 20 min and removing supernatant
(soluble protein). 300 µl of each sample was loaded onto a His-Spin Protein Mini-
prep column (Zymo) and purified using the manufacturer’s protocol. All samples
were eluted in 150 µl of elution buffer. Gel-code blue-stained SDS–PAGE gel lanes
were subdivided into 7 regions and cut into ~2mm squares. These were washed
overnight in 50% methanol/water. These were washed once more with 1:1
methanol:water overnight, dehydrated with acetonitrile and dried in a speed-vac.
Reduction and alkylation of disulfide bonds were then carried out by the addition
of 30 µl 10 mM dithiothreitol (DTT) in 100 mM ammonium bicarbonate for
30 min to reduce disulfide bonds. The resulting free cysteine residues were sub-
jected to an alkylation reaction by removal of the DTT solution and the addition of
100 mM iodoacetamide in 100 mM ammonium bicarbonate for 30 min to form
carbamidomethyl cysteine. These were then sequentially washed with aliquots of
acetonitrile, 100 mM ammonium bicarbonate, and acetonitrile and dried in a
speed-vac. The bands were enzymatically digested by the addition of 300 ng of
trypsin (or chymotrypsin for R or K qtRNAs) in 50 mM ammonium bicarbonate to
the dried gel pieces for 10 min on ice. Depending on 22the volume of acrylamide,
excess ammonium bicarbonate was removed or enough was added to rehydrate the
gel pieces. These were allowed to digest overnight at 37 °C with gentle shaking. The
resulting peptides were extracted by the addition of 50 µl (or more if needed to
produce supernatant) of 50 mM ammonium bicarbonate with gentle shaking for
10 min. The supernatant from this was collected in a 0.5 ml conical autosampler
vial. Two subsequent additions of 47.5/47/5/5 acetonitrile/water/formic acid with
gentle shaking for 10 min were performed with the supernatant added to the 0.5 ml
autosampler vial. The organic solvent was removed and the volumes were reduced
to 15 µl using a speed-vac for subsequent analyses.
Chromatographic separations and analysis. Digested extracts were analyzed by
reversed-phase high-performance liquid chromatography (HPLC) using Waters
NanoAcquity pumps and autosampler and a ThermoFisher Orbitrap Elite mass
spectrometer using a nanoflow configuration. A 20 mm × 180 µm column packed
with 5 µm Symmetry C18 material (Waters) using a flow rate of 15 µl min−1 for
3 min was used to trap and wash peptides. These were then eluted onto the
analytical column which was a self-packed with 3.6 µm Aeris C18 material (Phe-
nomenex) in a fritted 20 cm × 75 µm fused silica tubing pulled to a 5 µm tip. The
gradient was isocratic 1% A Buffer for 1 min 250 nl min−1 with increasing B buffer
concentrations to 15% B at 20.5 min, 27% B at 31 min, and 40% B at 36 min. The
column was washed with high percent B and re-equilibrated between analytical
runs for a total cycle time of ~53 min. Buffer A consisted of 1% formic acid in water
and buffer B consisted of 1% formic acid in acetonitrile.
Mass spectrometry. The mass spectrometer was operated in a dependent data
acquisition mode where the 10 most abundant peptides detected in the Orbitrap
Elite (ThermoFisher) using full scan mode with a resolution of 240,000 were
subjected to daughter ion fragmentation in the linear ion trap. A running list of
parent ions was tabulated to an exclusion list to increase the number of peptides
analyzed throughout the chromatographic run. The resulting fragmentation spectra
were correlated against custom databases using PEAKS Studio X (Bioinformatics
Solutions). Calculation of Limit of Detection and relative abundance. The results
were matched to an sfGFP reference and analyzed for ≤2 amino acid substitutions
in a single tryptic fragment. The abundance of each residue substitution was
quantified by calculating the area under the curve of the ion chromatogram for
each peptide precursor. The limit of detection is 104 [AU], the lower limit for the
area under the curve for a peptide on this instrument.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Key plasmids described in this study will be deposited in Addgene. Unprocessed data files
and other plasmids will be made available upon reasonable request. Source data are
provided with this paper.
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